Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma.
about
Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.An integrated Taguchi and response surface methodological approach for the optimization of an HPLC method to determine glimepiride in a supersaturatable self-nanoemulsifying formulation.Rapid Analysis of Glibenclamide Using an Environmentally Benign Stability-Indicating RP-HPLC Method.Clinical pharmacokinetic study for the effect of glimepiride matrix tablets developed by quality by design concept.Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.
P2860
Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Development and validation of ...... dosage forms and human plasma.
@en
Development and validation of ...... dosage forms and human plasma.
@nl
type
label
Development and validation of ...... dosage forms and human plasma.
@en
Development and validation of ...... dosage forms and human plasma.
@nl
prefLabel
Development and validation of ...... dosage forms and human plasma.
@en
Development and validation of ...... dosage forms and human plasma.
@nl
P2093
P2860
P356
P1476
Development and validation of ...... dosage forms and human plasma
@en
P2093
Amina A Abdelal
Mitsuhiro N Nakamura
Nahed M El-Enany
Yoshinori I Itoh
P2860
P2888
P356
10.1186/1752-153X-6-9
P577
2012-01-26T00:00:00Z
P6179
1031866964